Gastrointestinal Malignancies in 2020 and Beyond

Latest therapeutic developments in GI cancer treatment from the WCGI congress, and implications on individualized clinical decision-making. How will emerging data shape future treatment paradigms?

July 6 & 10, 2020
Gerald Prager MD Aptitude Health 2020 GI


Gerald Prager, MD

Medical University of Vienna, Vienna, Austria

Howard Hochster, MD, FACP, Aptitude Health Scientific Leader


Howard Hochster, MD, FACP

Rutgers Cancer Institute, Houston, TX, US

Faculty Members

Chiara Cremolini, MD
Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center, Hamburg, Germany

Fotios Loupakis, MD, PhD
Veneto Institute of Oncology, Padua, Italy

Axel Grothey, MD
West Cancer Center, Germantown, TN, US

Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France

Philip A. Philip, MD, PhD
Barbara Ann Karmanos Cancer Institute, Detroit, MI, US

Elizabeth C. Smyth, MD
Memorial Sloan Kettering Cancer Center, New York, NY, US

Jordi Bruix, MD, PhD
University of Barcelona, Barcelona, Spain

Juan Valle, MD, PhD
University of Manchester, Manchester, UK

Tanios S. Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ, US

Marc Peeters, MD, PhD
Antwerp University Hospital, Antwerp, Belgium

Sample Report

Start discovering the insights

View Report


  • Metastatic Colorectal Cancers
    • Recent Insights and Future Approaches: Chemotherapy and Targeted Therapies
    • Recent Insights and Future Approaches: Immunotherapy and Targeted Therapies
  • Gastroesophageal Cancers
  • Hepatocellular and Biliary Tract Cancers
  • Biology-Guided Treatment of Locally Advanced/Metastatic Pancreatic Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.